Crossmark

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers

Crossref DOI link: https://doi.org/10.1186/s40425-019-0737-3

Published Online: 2019-10-17

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Hao-Xiang

Chen, Yan-Xing

Wang, Zi-Xian

Zhao, Qi

He, Ming-Ming

Wang, Ying-Nan

Wang, Feng

Xu, Rui-Hua https://orcid.org/0000-0001-9771-8534
Funding

Funding for this research was provided by:

National Key R&D Program of China (2018YFC1313300)

Natural Science Foundation of Guangdong Province (2017A030313485, 2014A030312015)

Science and Technology Program of Guangdong (2019B020227002)
License Information

Text and Data Mining valid from 2019-10-17
More Information

Article History

Received: 24 July 2019

Accepted: 11 September 2019

First Online: 17 October 2019

Ethics approval and consent to participate

: Ethical approval was waived since we used only publicly available data and materials in this study.

: Not applicable.

: The authors declare that they have no competing interests.